---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-090015"
form_type: "8-K"
ticker: "XAGE"
cik: "0001842939"
company_name: "Longevity Health Holdings, Inc."
filed_at: "2025-06-25T23:59:59+00:00"
generated_at: "2026-05-18T19:55:41.097169+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Longevity Health extends merger deadline with 20/20 Biolabs to July 8, 2025

## Summary
- Due Diligence Contingency Deadline moved to July 8, 2025; merger agreement will auto-terminate on that date unless extended in writing.
- Amendment signed June 24, 2025; original Agreement and Plan of Merger dated April 11, 2025.
- No other provisions of the merger agreement were modified beyond the deadline extension.
- Parties: Longevity Health Holdings, Merger Sub, 20/20 Biolabs, and stockholder representative Jonathan Cohen.

## SEC filing metadata
- accession: 0000950170-25-090015
- form_type: 8-K
- ticker: XAGE
- cik: 0001842939
- company_name: Longevity Health Holdings, Inc.
- filed_at: 2025-06-25T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842939/000095017025090015/0000950170-25-090015-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842939/000095017025090015/xage-20250624.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-090015
- JSON: https://secwatch.observer/filing/0000950170-25-090015.json
- Plain text: https://secwatch.observer/filing/0000950170-25-090015.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.